Trump Halts Lifesaving HIV Aid Program, Sparking Global Health Crisis Concerns

President Donald Trump has ordered the shutdown of a longstanding global health program, the President’s Emergency Plan for AIDS Relief (PEPFAR), which has saved millions of lives by providing HIV medications to low-income countries, The New York Times reported. The suspension halts the program’s operations, even blocking access to medications already delivered to local clinics.

PEPFAR, established under the George W. Bush administration, has been hailed as one of the most successful U.S. foreign aid initiatives, saving an estimated 25 million lives worldwide, particularly in African nations ravaged by HIV. Despite its success, the program is being halted as part of Trump’s broader directive to suspend most foreign aid for three months, with exceptions only for emergency food assistance and arms deals for Egypt and Israel.

More: Supreme Court Case on ACA Could Undermine HIV Care and Preventative Health Policies

More: New “Highly Virulent” Strain Of HIV Discovered In The Netherlands

According to The New York Times, the suspension came with little warning. On Monday afternoon, officials worldwide were informed via email that PEPFAR’s data systems would shut down by 6 p.m. Eastern—just three hours after the notice was sent. This abrupt shutdown has raised fears among experts that the program may not resume after the temporary foreign aid pause.

The consequences of this decision are already being felt. “Appointments are being canceled, and patients are being turned away from clinics,” the report stated, citing sources who spoke anonymously for fear of retribution. Without access to life-saving antiretroviral drugs, people with HIV face rapid deterioration of their health, increased vulnerability to opportunistic infections, and a heightened risk of transmitting the virus to others.

PEPFAR’s suspension has drawn sharp criticism from public health experts, who warn of catastrophic consequences. The program is a critical lifeline for many countries, with some, like South Africa, relying on it for 20% of their HIV budget, while poorer nations are almost entirely dependent on it. A study cited by The New York Times estimates that the termination of PEPFAR could result in 600,000 deaths in South Africa alone over the next decade.

The decision also follows Trump’s move to withdraw the U.S. from the World Health Organization, which has faced GOP criticism for alleged favoritism toward China during the COVID-19 pandemic. Republican lawmakers skeptical of family planning services have long targeted PEPFAR, despite its focus on combating HIV.

More: Trump’s Withdrawal from WHO Sparks Global Health and National Security Concerns

More: Nobel Laureates Warn RFK Jr.’s DHHS Appointment Threatens Public Health

Critics note that even before Trump’s re-election, PEPFAR was under threat, with budget cuts proposed during Joe Biden’s administration. However, the complete halt of the program under Trump’s directive marks a significant escalation, with experts warning of widespread health crises in affected regions.

This suspension, which interrupts decades of progress in global HIV treatment, raises serious questions about the U.S. commitment to international public health and the future of humanitarian aid initiatives.